These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8341771)

  • 21. The prolactin response in schizophrenic, schizophreniform, and manic disorders.
    Hitzemann R; Hirschowitz J; Hitzemann B; Garver D
    Biol Psychiatry; 1984 Jun; 19(6):913-8. PubMed ID: 6743725
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolactin response to submaximal stimulation by TRH in nonaffective psychoses.
    Spoov J; Bredbacka PE; Appelberg B; Katila H; Karonen SL; Rimón R; Sarna S
    Biol Psychiatry; 1991 Feb; 29(3):204-10. PubMed ID: 1673063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
    Csernansky JG; Kaplan J; Holman CA; Hollister LE
    Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients.
    Kirkpatrick B; Carpenter WT; Maeda K; Buchanan RW; Breier A; Tamminga CA
    Biol Psychiatry; 1992 Dec; 32(11):1049-54. PubMed ID: 1467385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower prolactin bioactivity in unmedicated schizophrenic patients.
    Warner MD; Walker AM; D'Souza DC; Lee D; Nasseri D; Peabody CA
    Psychiatry Res; 2001 Jul; 102(3):249-54. PubMed ID: 11440775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects.
    Kahn RS; Davidson M; Hirschowitz J; Stern RG; Davis BM; Gabriel S; Moore C; Davis KL
    Psychiatry Res; 1992 Feb; 41(2):155-61. PubMed ID: 1574542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
    Rao ML; Brown WA
    Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
    Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
    Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Circadian changes in serum prolactin in a group of apparently healthy subjects].
    Tarquini B; Gheri R; Neri B; Palma R; Costa A; Legnaioli M
    Arch Sci Med (Torino); 1977; 134(4):395-8. PubMed ID: 610688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin shifts after neuroleptic withdrawal.
    Green AI; Faraone SV; Brown WA
    Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolactin responses to domperidone in chronic schizophrenia.
    Nerozzi D; Magnani A; Dastoli C; Ferri E; Capesciotti G; Antonozzi I; Frajese G; Meltzer HY
    Psychiatry Res; 1992 May; 42(2):159-69. PubMed ID: 1631251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine.
    Mann K; Rossbach W; Müller MJ; Müller-Siecheneder F; Pott T; Linde I; Dittmann RW; Hiemke C
    Psychoneuroendocrinology; 2006 Feb; 31(2):256-64. PubMed ID: 16185814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.
    Mihara K; Kondo T; Suzuki A; Yasui N; Nagashima U; Ono S; Otani K; Kaneko S
    Psychopharmacology (Berl); 2000 Apr; 149(3):246-50. PubMed ID: 10823405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of serum prolactin levels in schizophrenia: comparison of males and females.
    Kuruvilla A; Peedicayil J; Srikrishna G; Kuruvilla K; Kanagasabapathy AS
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):603-6. PubMed ID: 1356671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
    Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
    Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seasonal variations in prolactin levels in schizophrenia.
    Brown PJ; Cleghorn JM; Brown GM; Kaplan RD; Mitton J; Szechtman H; Szechtman B
    Psychiatry Res; 1988 Aug; 25(2):157-62. PubMed ID: 3174903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ratio of serum prolactin to haloperidol and early clinical outcome in acute psychosis.
    Swigar ME; Jatlow PI; Goicoechea N; Opsahl C; Bowers MB
    Am J Psychiatry; 1984 Oct; 141(10):1281-3. PubMed ID: 6486269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin levels in drug-naïve patients with schizophrenia and other psychotic disorders.
    Petrikis P; Tigas S; Tzallas AT; Archimandriti DT; Skapinakis P; Mavreas V
    Int J Psychiatry Clin Pract; 2016 Sep; 20(3):165-9. PubMed ID: 27334805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.